We are live on ! Find out more
DTIL icon

Precision BioSciences
DTIL

130 hedge funds and large institutions have $357M invested in Precision BioSciences in 2021 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 44 increasing their positions, 42 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

70% more call options, than puts

Call options by funds: $2.6M | Put options by funds: $1.53M

17% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 18

14% more capital invested

Capital invested by funds: $313M → $357M (+$44.3M)

2% more funds holding

Funds holding: 128 → 130 (+2)

5% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 42

0.11% less ownership

Funds ownership: 1.77% → 1.67% (-0.11%)

Holders
130
Holders Change
+2
Holders Change %
+1.56%
% of All Funds
2.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
44
Reduced
42
Closed
18
Calls
$2.6M
Puts
$1.53M
Net Calls
+$1.07M
Net Calls Change
+$1.14M

Top Buyers

Rank Fund Capital Flow
1
CS
Candriam SCA
Luxembourg
+$6.34M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$4.8M
3
JP Morgan Chase
JP Morgan Chase
New York
+$3.13M
4
Morgan Stanley
Morgan Stanley
New York
+$2.18M
5
Capital World Investors
Capital World Investors
California
+$2.07M

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$23.7M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$5.38M
3
UBS Group
UBS Group
Switzerland
-$3.13M
4
BlackRock
BlackRock
New York
-$2.97M
5
GTC
Ghost Tree Capital
New York
-$2.07M
Name Holding Trade Value Shares
Change 		Change in
Stake
Capital World Investors
1
Capital World Investors
California
$53.4M +$2.07M +6,900 +5%
BlackRock
2
BlackRock
New York
$48.9M -$2.97M -9,884 -7%
Vanguard Group
3
Vanguard Group
Pennsylvania
$35M +$4.8M +15,968 +21%
State Street
4
State Street
Massachusetts
$34.9M -$23.7M -78,743 -46%
ACH
5
ArrowMark Colorado Holdings
Colorado
$27.6M -$275K -914 -1%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$9.78M +$603K +2,007 +8%
Morgan Stanley
7
Morgan Stanley
New York
$9.47M +$2.18M +7,255 +40%
CA
8
CHI Advisors
New York
$8.16M -$399K -1,330 -6%
CS
9
Candriam SCA
Luxembourg
$7.93M +$6.34M +21,105 New
T. Rowe Price Associates
10
T. Rowe Price Associates
Maryland
$7.47M -$317K -1,056 -5%
Northern Trust
11
Northern Trust
Illinois
$6.58M +$307K +1,021 +6%
JP Morgan Chase
12
JP Morgan Chase
New York
$6.46M +$3.13M +10,436 +154%
Millennium Management
13
Millennium Management
New York
$6.43M -$9.01K -30 -0.2%
Principal Financial Group
14
Principal Financial Group
Iowa
$5.77M +$422K +1,404 +10%
MSAM
15
Moloney Securities Asset Management
Missouri
$4.53M -$514K -1,710 -12%
CAM
16
Cormorant Asset Management
Massachusetts
$4.34M – – –
Charles Schwab
17
Charles Schwab
California
$3.98M +$189K +629 +6%
SCM
18
Sio Capital Management
New York
$3.67M -$360K -1,198 -11%
Fidelity Investments
19
Fidelity Investments
Massachusetts
$3.46M -$5.38M -17,928 -66%
Goldman Sachs
20
Goldman Sachs
New York
$3.32M +$1.96M +6,525 +282%
Citigroup
21
Citigroup
New York
$2.94M -$1.57M -5,224 -40%
JAMONY
22
Jacob Asset Management of New York
California
$2.64M +$721K +2,400 +52%
ACWM
23
Adams Chetwood Wealth Management
North Carolina
$2.26M – – –
IHAM
24
Integral Health Asset Management
New York
$2.19M +$1.75M +5,833 New
HF
25
HRT Financial
New York
$2.14M +$1.71M +5,702 New
1
2 3 4 5

DTIL Hedge Fund Activity: Q2 2021 in Review

130 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q2 2021, worth a combined $357M — up 14% from $313M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new DTIL positions and 18 closed out — a net gain of 3 holders — while 44 added to existing stakes and 42 trimmed.

The largest buyer was Candriam SCA, opening a new position worth an estimated $6.34M. The largest seller was State Street, cutting an estimated $23.7M.

  • 130 institutional investors held Precision BioSciences (DTIL) as of Q2 2021, up from 128 in Q1 2021.
  • Funds reported $357M of Precision BioSciences stock for Q2 2021, up 14% quarter-over-quarter.
  • 21 funds opened new Precision BioSciences positions in Q2 2021 and 18 closed out, a net change of +3 holders.
  • The largest Precision BioSciences buyer in Q2 2021 was Candriam SCA, an estimated $6.34M added.
  • The largest Precision BioSciences seller in Q2 2021 was State Street, an estimated $23.7M sold.

Based on aggregated 13F filings for Q2 2021.